Lung cancer survival rates improved through use of individualized chemotherapy
Sunday, September 12, 2010 - 20:21
in Health & Medicine
Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing knowledge, a new study has analyzed the usefulness of adjuvant chemotherapy for non-small cell lung cancer based on the histoculture drug response assay.